Daniel C. Adelman M.D., Chief Medical Officer at Aimmune Therapeutics, Inc. (AIMT), sold 36,717 shares at $40.00 ($1.5M) on 2018-01-12, disclosed to the SEC on 2018-01-16.
Open-market sale of $1.5M AIMT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 26,784 | $1.1M | 72.9% |
| 2 | $40.00 | 9,933 | $397K | 27.1% |
| Total | $40.00 avg | 36,717 | $1.5M | 100% |
| Filing → |
| AIMT | SELL | 2017-12-29 | $131K | — | Filing → |
| AIMT | SELL | 2017-10-25 | $575K | — | Filing → |
| AIMT | SELL | 2017-09-27 | $250K | — | Filing → |